Detection of soluble forms of platelet membrane glycoproteins and its clinical significance

M. Handa, M. Katayama, Y. Ikeda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Soluble forms of surface membrane glycoproteins of various cell types have been identified as makers for in vivo or in vitro cellular events, in which the receptors are involved. Using mouse monoclonal antibodies, sandwich ELISA systems to quantitate plasma concentrations of two platelet glycoproteins in soluble form were set up: one is glycocalicin (GC), a proteolytic fragment of GP Ib alpha chain and the other is GMP-140 or CD62 (GMP) known as a target for leukocyte recruitment at vascular injury sites. As in vivo markers, GC is said to reflect platelet turnover. High levels of plasma GMP were detected in patients with thrombotic thrombocytopenic purpura, being presumably indicative of microcirculation disorder. During storage of platelet concentrates, plasma levels of both markers were increased in a time-dependent fashion over 10 days. This correlated with a decrease in the surface expression of the glycoproteins on platelets, suggesting that the soluble glycoproteins entering the supernatants by proteolysis would be an useful indicator for in vitro alteration of stored platelets surface.

Original languageEnglish
Pages (from-to)360-365
Number of pages6
JournalNippon rinsho. Japanese journal of clinical medicine
Volume50
Issue number2
Publication statusPublished - 1992 Feb

Fingerprint

Platelet Membrane Glycoproteins
Membrane Glycoproteins
Blood Platelets
Thrombotic Thrombocytopenic Purpura
P-Selectin
Vascular System Injuries
Microcirculation
Proteolysis
Glycoproteins
Leukocytes
Enzyme-Linked Immunosorbent Assay
Monoclonal Antibodies
In Vitro Techniques
glycocalicin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Detection of soluble forms of platelet membrane glycoproteins and its clinical significance. / Handa, M.; Katayama, M.; Ikeda, Y.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 50, No. 2, 02.1992, p. 360-365.

Research output: Contribution to journalArticle

@article{555327499e6940b19a3d6752ee32dd90,
title = "Detection of soluble forms of platelet membrane glycoproteins and its clinical significance",
abstract = "Soluble forms of surface membrane glycoproteins of various cell types have been identified as makers for in vivo or in vitro cellular events, in which the receptors are involved. Using mouse monoclonal antibodies, sandwich ELISA systems to quantitate plasma concentrations of two platelet glycoproteins in soluble form were set up: one is glycocalicin (GC), a proteolytic fragment of GP Ib alpha chain and the other is GMP-140 or CD62 (GMP) known as a target for leukocyte recruitment at vascular injury sites. As in vivo markers, GC is said to reflect platelet turnover. High levels of plasma GMP were detected in patients with thrombotic thrombocytopenic purpura, being presumably indicative of microcirculation disorder. During storage of platelet concentrates, plasma levels of both markers were increased in a time-dependent fashion over 10 days. This correlated with a decrease in the surface expression of the glycoproteins on platelets, suggesting that the soluble glycoproteins entering the supernatants by proteolysis would be an useful indicator for in vitro alteration of stored platelets surface.",
author = "M. Handa and M. Katayama and Y. Ikeda",
year = "1992",
month = "2",
language = "English",
volume = "50",
pages = "360--365",
journal = "Nihon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "2",

}

TY - JOUR

T1 - Detection of soluble forms of platelet membrane glycoproteins and its clinical significance

AU - Handa, M.

AU - Katayama, M.

AU - Ikeda, Y.

PY - 1992/2

Y1 - 1992/2

N2 - Soluble forms of surface membrane glycoproteins of various cell types have been identified as makers for in vivo or in vitro cellular events, in which the receptors are involved. Using mouse monoclonal antibodies, sandwich ELISA systems to quantitate plasma concentrations of two platelet glycoproteins in soluble form were set up: one is glycocalicin (GC), a proteolytic fragment of GP Ib alpha chain and the other is GMP-140 or CD62 (GMP) known as a target for leukocyte recruitment at vascular injury sites. As in vivo markers, GC is said to reflect platelet turnover. High levels of plasma GMP were detected in patients with thrombotic thrombocytopenic purpura, being presumably indicative of microcirculation disorder. During storage of platelet concentrates, plasma levels of both markers were increased in a time-dependent fashion over 10 days. This correlated with a decrease in the surface expression of the glycoproteins on platelets, suggesting that the soluble glycoproteins entering the supernatants by proteolysis would be an useful indicator for in vitro alteration of stored platelets surface.

AB - Soluble forms of surface membrane glycoproteins of various cell types have been identified as makers for in vivo or in vitro cellular events, in which the receptors are involved. Using mouse monoclonal antibodies, sandwich ELISA systems to quantitate plasma concentrations of two platelet glycoproteins in soluble form were set up: one is glycocalicin (GC), a proteolytic fragment of GP Ib alpha chain and the other is GMP-140 or CD62 (GMP) known as a target for leukocyte recruitment at vascular injury sites. As in vivo markers, GC is said to reflect platelet turnover. High levels of plasma GMP were detected in patients with thrombotic thrombocytopenic purpura, being presumably indicative of microcirculation disorder. During storage of platelet concentrates, plasma levels of both markers were increased in a time-dependent fashion over 10 days. This correlated with a decrease in the surface expression of the glycoproteins on platelets, suggesting that the soluble glycoproteins entering the supernatants by proteolysis would be an useful indicator for in vitro alteration of stored platelets surface.

UR - http://www.scopus.com/inward/record.url?scp=0026815183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026815183&partnerID=8YFLogxK

M3 - Article

C2 - 1613991

AN - SCOPUS:0026815183

VL - 50

SP - 360

EP - 365

JO - Nihon rinsho. Japanese journal of clinical medicine

JF - Nihon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 2

ER -